SEC Form 4 · accession 0001171843-26-003899
Brainsway Ltd. · BWAY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yiftach Roth
Officer — Chief Scientist
Period of report
Jun 1, 2026
Accepted (ET)
Jun 3, 2026 · 4:02 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001505065
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2,F3 | Jun 1, 2026 | S$0 | 2,000 | — | D | 1,077,305 | D | |
| Ordinary SharesF1,F4,F3 | Jun 1, 2026 | S$0 | 2,000 | — | D | 1,075,305 | D | |
| Ordinary SharesF1,F5,F3 | Jun 2, 2026 | S$0 | 1,000 | — | D | 1,074,305 | D | |
| Ordinary SharesF1,F6,F3 | Jun 2, 2026 | S$0 | 2,000 | — | D | 1,072,305 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- F2The sale price was NIS 43.64 per share.
- F3This figure includes ordinary shares held jointly by Dr. Roth and his spouse and (i) 15,000 ordinary shares and (ii) unvested restricted stock units ("RSUs") to receive 5,000 ordinary shares, with 1,250 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030, each RSU representing a contingent right to receive one ordinary share.
- F4The sale price was NIS 43.45 per share.
- F5The sale price was NIS 43 per share.
- F6The sale price was NIS 42.0035 per share.